Guidance for the development of a selective-reporting or cascade-reporting protocol for antibiotics is available from the
A) Centers for Disease Control and Prevention (CDC).
B) Clinical Laboratory and Standards Institute (CLSI).
C) United States Army Medical Research Institute (USAMRIID).
D) Food and Drug Administration (FDA).

Question

Quizplus · Accepted Answer

The Clinical Laboratory and Standards Institute (CLSI) provides guidance on the development of protocols for reporting antibiotic susceptibility results in a selective or cascade manner. The CLSI is an international organization that sets standards and guidelines for clinical laboratory testing. The other options listed may have some involvement in antibiotic regulation or research, but they do not specialize in providing guidance for laboratory testing protocols.

Guidance for the Development of a Selective-Reporting or Cascade-Reporting Protocol